Accretion Nutraveda Ltd. Logo

Accretion Nutraveda Ltd. (ANL)

BSE

Currency in INR
289.05
-23.95 (-7.65%)

Closed

Aug 25, 2026

Day's Range

288.05
290.00

52 wk Range

150.10
313.00

Overview - ANL - Accretion Nutraveda Ltd.

Key Statistics

Valuation

Enterprise Value

2.01B

P/E (Trailing)

‪33.47‬

Price / Sales (TTM)

‪6.74‬

Price / Book

‪6.38‬

EV / EBITDA

‪29.17‬

Profitability

Profit Margin

‪15.07%‬

Operating Margin

‪17.98%‬

Return on Assets

‪15.88%‬

Return on Equity

‪25.01%‬

Ownership

Shares Outstanding

7.24M

Float

1.84M

Held by Insiders

‪82.87%‬

Held by Institutions

‪0.00%‬

Price stats

50-Day Avg

‪273.48‬

200-Day Avg

‪238.88‬

Dividends

Payout Ratio

‪0.00%‬

Shariah Compliance

Shariah Compliant

Report Date: Feb 18, 2025

Screened by Zoya using the AAOIFI methodology.

Peers - ANL - Accretion Nutraveda Ltd.

Peer Comparison

Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.

Profile Summary - ANL - Accretion Nutraveda Ltd.

About

Accretion Nutraveda Ltd. is a healthcare-focused Contract Development and Manufacturing Organization (CDMO) specializing in Ayurvedic, nutraceutical, and pharmaceutical products. Founded on March 16, 2021, in Ahmedabad, Gujarat, India, the company manufactures a diverse range of dosage forms, including tablets,…

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.